Maria Ortiz Urda, M.D
NPI 1154574853 · Dermatology Physician · Stanford, CA
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1154574853
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D
- Sex
- Female
- Sole proprietor
- No
- License
- A105136 (CA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
17 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
6 documented practice locations
- Medicare service volume (vs. specialty peers)25% of score
4,509 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 1,391 | $7 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 735 | $96 |
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 496 | $2 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 412 | $57 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 308 | $74 |
| Biopsy of Related Skin Growth, First Growth11102 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 19 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Ketoconazole | 134 | 69 |
| Triamcinolone Acetonide | 105 | 78 |
| Fluorouracil | 72 | 51 |
| Clobetasol Propionate | 71 | 45 |
| Fluocinonide | 53 | 35 |
| Hydrocortisone | 27 | 23 |
| Prednisone | 27 | — |
| Doxycycline Hyclate | 25 | 24 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$58 across 3 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (5)
- 991 Montague Expy Ste 104Milpitas, CA 95035-6809Phone: (408) 263-6073Fax: (408) 263-6077
- 525 South Dr Ste 115Mountain View, CA 94040-4211Phone: (650) 969-5600Fax: (650) 969-0360
- 2420 Samaritan DrSan Jose, CA 95124-3907Phone: (408) 369-5600Fax: (408) 369-5625
- 3562 Round Barn Cir Ste 320Santa Rosa, CA 95403-0182Phone: (707) 578-1900Fax: (707) 578-1111
- 603 S Knickerbocker DrSunnyvale, CA 94087-1034Phone: (408) 736-0441Fax: (408) 736-0722
Registry dates
- Enumerated
- 2008-10-28
- Last updated
- 2021-09-28
- Certified
- 2021-09-28
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.